Jaguar Animal Health, Inc. (NASDAQ:JAGX) registered a 56.60% increase, still its new closing price is 66.00% up from the company’s 1 year high of 3.79.It posted 62.65% gains in previous 5 sessions and is now the subject of 0 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 0 buy or better ratings. The 2 stock analysts following this company have an average price target at $6.50, with individual PT in the $3.00-$10.00 range. The shares moved at $0.83, implying that brokerage firms see shares losing about -69.93% in twelve months time.
Jaguar Animal Health, Inc. (JAGX) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a 15.92% rise year to date. A Director at Jaguar Animal Health, Inc. (JAGX) acquired shares in a transaction closed on Monday February 08, 2016. BOCHNOWSKI JAMES J bought 20,000 shares in the company at $2.5 each and collected $400,000 in proceeds. BOCHNOWSKI JAMES J now owns 160,000 shares in the company after this transaction.
Jaguar Animal Health, Inc. (NASDAQ:JAGX) Upcoming Results on Tap
Jaguar Animal Health, Inc. will next provide financial results for the December 2017 quarter. Stock analysts expect it to report per-share earnings of $-0.15 in that period. Sales during the quarter are predicted to arrive at $4.2 million.
Earnings surprise history: Last quarter, the company posted approximately $0 in revenue and EPS of $-0.30. The mean forecast was for $0 and $-0.40 a share, respectively. One quarter earlier, revenue for the stock was at $0, with earnings at $-0.35/share.
Jaguar Animal Health, Inc. (JAGX) Brokerage Update
Over the last six months and over the last three months, the shares of Jaguar Animal Health, Inc. (JAGX), have changed -50.89% and -9.78%, respectively.